Valuation: Bayer AG

Market Cap 4.79TCr 5.52TCr 4.52TCr 4.11TCr 7.7TCr 5,29700Cr 7.74TCr 54TCr 21TCr 2,68700Cr 21TCr 20TCr 8,56400Cr P/E 2026 *
22x
P/E 2027 * 15.9x
Enterprise Value 7.78TCr 8.98TCr 7.35TCr 6.68TCr 13TCr 8,61300Cr 13TCr 88TCr 34TCr 4,36900Cr 34TCr 33TCr 13,92500Cr EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.15%
1 week-0.32%
Current month-0.36%
1 month+2.24%
3 months+36.28%
6 months+21.95%
Current year+32.46%
1 week 47.74
Extreme 47.74
50.32
1 month 47.44
Extreme 47.445
50.32
3 years 18.39
Extreme 18.39
53.9
5 years 18.39
Extreme 18.39
67.99
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+1.15%+82.31%-0.85% 5.52TCr
-0.20%+1.02%+48.50%+98.79% 1,01300Cr
+0.25%+0.23%+51.70%+64.76% 64TCr
-0.36%+4.44%+21.17%+70.22% 46TCr
+0.53%+4.26%+40.29%+40.53% 35TCr
+0.39%+2.35%+17.96%+24.19% 26TCr
+0.17%+4.17%+6.96%+13.12% 25TCr
+0.09%-3.92%+37.66%+42.86% 20TCr
-1.20%-5.64%-24.09%-58.09% 19TCr
+0.74%+1.18%+32.93%+94.88% 18TCr
Average +0.01%-1.08%+31.54%+39.04% 39.6TCr
Weighted average by Cap. -0.02%+0.01%+34.97%+58.93%

Financials

2026 *2027 *
Net sales 4.58TCr 5.28TCr 4.33TCr 3.93TCr 7.36TCr 5,06700Cr 7.41TCr 52TCr 20TCr 2,57000Cr 20TCr 19TCr 8,19200Cr 4.7TCr 5.42TCr 4.44TCr 4.03TCr 7.56TCr 5,20100Cr 7.6TCr 53TCr 20TCr 2,63800Cr 20TCr 20TCr 8,40900Cr
Net income 214.18Cr 247.15Cr 202.44Cr 183.78Cr 344.45Cr 24TCr 346.51Cr 2.42TCr 933.84Cr 12TCr 928.43Cr 907.82Cr 38TCr 293.77Cr 338.99Cr 277.66Cr 252.07Cr 472.44Cr 33TCr 475.26Cr 3.31TCr 1.28TCr 16TCr 1.27TCr 1.25TCr 53TCr
Net Debt 3TCr 3.46TCr 2.83TCr 2.57TCr 4.82TCr 3,31600Cr 4.85TCr 34TCr 13TCr 1,68200Cr 13TCr 13TCr 5,36000Cr 2.68TCr 3.1TCr 2.54TCr 2.3TCr 4.31TCr 2,96900Cr 4.34TCr 30TCr 12TCr 1,50600Cr 12TCr 11TCr 4,80000Cr
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
16/26/16 49.01 +0.32%
15/26/15 €48.85 -0.85%
14/26/14 €49.27 +2.76%
11/26/11 €47.95 -1.77%
10/26/10 €48.81 -0.71%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.71EUR
Average target price
58.22EUR
Spread / Average Target
+19.53%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!